» Articles » PMID: 29587848

Cytokeratin 5/6 Expression in Bladder Cancer: Association with Clinicopathologic Parameters and Prognosis

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2018 Mar 29
PMID 29587848
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Well differentiated keratinized squamous component as a part of urothelial carcinoma can be easily appreciated; however non-keratinizing squamous differentiation closely resembles urothelial differentiation. In addition prognostic significance of CK 5/6 expression in the absence of apparent squamous differentiation is still unclear. Therefore, in the present study we aimed to evaluate the frequency of CK 5/6 expression in 127 cases of urothelial carcinoma and its prognostic significance in loco-regional population.

Results: Positive CK5/6 expression was noted in 6.3% (8 cases) and 13.4% (17 cases) revealed focal positive CK 5/6 expression. On the other hand, 80.3% (102 cases) showed negative CK5/6 staining. Significant association of CK5/6 expression was noted with tumor grade and muscularis propria invasion, however no significant association was noted with overall and disease free survival. On the basis of the results of our study we can conclude that CK5/6 is an independent prognostic biomarker in urothelial carcinoma and therefore can be used in the prognostic stratification of the patients with bladder cancer.

Citing Articles

CK5/6 Expression in Molecular Subtypes of Invasive Ductal Carcinoma.

Yasin R, Zafar G, Rooman Ali Syed F, Afzal S, Fatima M, Rathore Z Cureus. 2024; 16(10):e72608.

PMID: 39610583 PMC: 11603255. DOI: 10.7759/cureus.72608.


Renal pelvic plasmacytoid subtype urothelial carcinoma accompanied with solitary mammary metastasis.

Matsubara K, Hayakawa N, Aida K, Koike J, Kikuchi E Int Cancer Conf J. 2024; 13(3):296-300.

PMID: 38962031 PMC: 11217202. DOI: 10.1007/s13691-024-00681-7.


Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression.

Sanguedolce F, Zanelli M, Palicelli A, Ascani S, Zizzo M, Cocco G Int J Mol Sci. 2022; 23(14).

PMID: 35887164 PMC: 9319819. DOI: 10.3390/ijms23147819.


(Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder.

Larrinaga G, Calvete-Candenas J, Solano-Iturri J, Martin A, Pueyo A, Nunes-Xavier C Cancers (Basel). 2021; 13(22).

PMID: 34830803 PMC: 8616163. DOI: 10.3390/cancers13225642.


Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer.

Bejrananda T, Kanjanapradit K, Saetang J, Sangkhathat S Sci Rep. 2021; 11(1):21186.

PMID: 34707176 PMC: 8551252. DOI: 10.1038/s41598-021-00628-5.


References
1.
PEARSE H, Reed R, Hodges C . Radical cystectomy for bladder cancer. J Urol. 1978; 119(2):216-8. DOI: 10.1016/s0022-5347(17)57437-6. View

2.
Gaisa N, Braunschweig T, Reimer N, Bornemann J, Eltze E, Siegert S . Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Virchows Arch. 2010; 458(3):301-12. DOI: 10.1007/s00428-010-1017-2. View

3.
SKINNER D, Lieskovsky G . Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol. 1984; 131(6):1069-72. DOI: 10.1016/s0022-5347(17)50809-5. View

4.
Kaufmann O, Fietze E, Mengs J, Dietel M . Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2002; 116(6):823-30. DOI: 10.1309/21TW-2NDG-JRK4-PFJX. View

5.
Langner C, Wegscheider B, Rehak P, Ratschek M, Zigeuner R . Prognostic value of keratin subtyping in transitional cell carcinoma of the upper urinary tract. Virchows Arch. 2004; 445(5):442-8. DOI: 10.1007/s00428-004-1088-z. View